No headlines found.
Nu Skin Enterprises to Discuss Company Strategy and Opportunities at ICR Conference
Business Wire (Fri, 9-Jan 7:00 AM ET)
Nu Skin Releases 2024 Social Impact and Sustainability Report
Business Wire (Tue, 30-Dec 6:01 PM ET)
Nu Skin Unveils Prysm iO : An Evolution in Intelligent Nutritional Wellness
Business Wire (Thu, 18-Dec 10:01 AM ET)
Nu Skin Enterprises Reports Third Quarter Earnings
Business Wire (Thu, 6-Nov 4:06 PM ET)
Nu Skin Enterprises Announces Quarterly Dividend
Business Wire (Thu, 6-Nov 4:05 PM ET)
Nu Skin Enterprises to Announce Third Quarter 2025 Financial Results
Business Wire (Thu, 16-Oct 4:05 PM ET)
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
Nu Skin Enterprises trades on the NYSE stock market under the symbol NUS.
As of January 13, 2026, NUS stock price climbed to $10.61 with 73,940 million shares trading.
NUS has a beta of 1.44, meaning it tends to be more sensitive to market movements. NUS has a correlation of 0.18 to the broad based SPY ETF.
NUS has a market cap of $517.24 million. This is considered a Small Cap stock.
Last quarter Nu Skin Enterprises reported $364 million in Revenue and $.34 earnings per share. This fell short of revenue expectation by $-10 million and exceeded earnings estimates by $.04.
In the last 3 years, NUS traded as high as $45.55 and as low as $5.32.
The top ETF exchange traded funds that NUS belongs to (by Net Assets): FNDA, AVUV, VTI, IWM, VDC.
NUS has outperformed the market in the last year with a price return of +74.4% while the SPY ETF gained +20.8%. However, in the short term, NUS had mixed performance relative to the market. It has underperformed in the last 3 months, returning +3.7% vs +6.5% return in SPY. But in the last 2 weeks, NUS shares have fared better than the market returning +9.0% compared to SPY +0.9%.
NUS support price is $10.20 and resistance is $10.70 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NUS shares will trade within this expected range on the day.